CLINICAL_TRIALS
trial_result
· 2022-08-17
Clinical Trial Update: HuoXin Pills Intervention on Patients With Coronary Heart Disease After Drug-Coated Balloon Implantation [Phase 4]
Summary
Phase 4 trial update evaluating HuoXin Pills for patients with coronary heart disease after drug-coated balloon implantation.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: China National Center for Cardiovascular Diseases | Conditions: Coronary Heart Disease, Medicine, Chinese Traditional | Phase 4 | Status: UNKNOWN